Search research articles
Contact Us
Filters
Showing results (101-110 of 242) with videos related to
Page
of 25
Sort By:
JMIR Public Health and Surveillance
|
February 14, 2024
Impact of the COVID-19 Pandemic on People Living With Rare Diseases and Their Families: Results of a National Survey
Maurizio Macaluso, Marc E Rothenberg, Thomas Ferkol, et al.
Journal of the Neurological Sciences
|
April 15, 2014
An ¹⁸F-FDG PET study of cervical muscle in parkinsonian anterocollis
Gonzalo J Revuelta, Jaime Montilla, Michael Benatar, et al.
Neurology
|
March 18, 2018
The state of clinical research in neurology
Deborah A Hall, Alberto R Ramos, Jeffrey Marc Gelfand, et al.
Neurology
|
October 3, 2025
Author Response: Genetic Associations With an Amyotrophic Lateral Sclerosis Reversal Phenotype
Jesse Ian Crayle, Jesse Ian Crayle, Evadnie Rampersaud, et al.
Annals of Neurology
|
December 19, 2023
Biomarker Qualification for Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: Theory and Practice
Michael Benatar, Lyle W Ostrow, Joseph W Lewcock, et al.
Neurology
|
July 30, 2024
Genetic Associations With an Amyotrophic Lateral Sclerosis Reversal Phenotype
Jesse I Crayle, Evadnie Rampersaud, Jason R Myers, et al.
Annals of Clinical and Translational Neurology
|
July 28, 2021
Humoral response to neurofilaments and dipeptide repeats in ALS progression
Fabiola Puentes, Vittoria Lombardi, Ching-Hua Lu, et al.
Neurology
|
February 24, 2017
Urinary p75<sup>ECD</sup>: A prognostic, disease progression, and pharmacodynamic biomarker in ALS
Stephanie R Shepheard, Joanne Wuu, Michell Cardoso, et al.
European Journal of Neurology
|
October 7, 2024
Time to response with ravulizumab, a long-acting terminal complement inhibitor, in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis
Ali A Habib, Michael Benatar, Tuan Vu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
August 28, 2024
Body mass index is lower in asymptomatic <i>C9orf72</i> expansion carriers but not in <i>SOD1</i> pathogenic variant carriers compared to gene negatives
Ikjae Lee, Mark A Garret, Joanne Wuu, et al.
Page
of 25
Search research articles
Search
Showing results (101-110 of 242) with videos related to
Sort By:
Page
of 25
JMIR Public Health and Surveillance
|
February 14, 2024
Impact of the COVID-19 Pandemic on People Living With Rare Diseases and Their Families: Results of a National Survey
Maurizio Macaluso, Marc E Rothenberg, Thomas Ferkol, et al.
Journal of the Neurological Sciences
|
April 15, 2014
An ¹⁸F-FDG PET study of cervical muscle in parkinsonian anterocollis
Gonzalo J Revuelta, Jaime Montilla, Michael Benatar, et al.
Neurology
|
March 18, 2018
The state of clinical research in neurology
Deborah A Hall, Alberto R Ramos, Jeffrey Marc Gelfand, et al.
Neurology
|
October 3, 2025
Author Response: Genetic Associations With an Amyotrophic Lateral Sclerosis Reversal Phenotype
Jesse Ian Crayle, Jesse Ian Crayle, Evadnie Rampersaud, et al.
Annals of Neurology
|
December 19, 2023
Biomarker Qualification for Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: Theory and Practice
Michael Benatar, Lyle W Ostrow, Joseph W Lewcock, et al.
Neurology
|
July 30, 2024
Genetic Associations With an Amyotrophic Lateral Sclerosis Reversal Phenotype
Jesse I Crayle, Evadnie Rampersaud, Jason R Myers, et al.
Annals of Clinical and Translational Neurology
|
July 28, 2021
Humoral response to neurofilaments and dipeptide repeats in ALS progression
Fabiola Puentes, Vittoria Lombardi, Ching-Hua Lu, et al.
Neurology
|
February 24, 2017
Urinary p75<sup>ECD</sup>: A prognostic, disease progression, and pharmacodynamic biomarker in ALS
Stephanie R Shepheard, Joanne Wuu, Michell Cardoso, et al.
European Journal of Neurology
|
October 7, 2024
Time to response with ravulizumab, a long-acting terminal complement inhibitor, in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis
Ali A Habib, Michael Benatar, Tuan Vu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
August 28, 2024
Body mass index is lower in asymptomatic <i>C9orf72</i> expansion carriers but not in <i>SOD1</i> pathogenic variant carriers compared to gene negatives
Ikjae Lee, Mark A Garret, Joanne Wuu, et al.
Page
of 25